BCL2 and metastatic malignant neoplasm in the lymph nodes: In particular, patients with colorectal adenocarcinoma without p-Bcl-2 (Ser70) expression exhibit shorter survival rates than patients with positive p-Bcl-2 (Ser70) expression, which is correlated with lymph node metastasis and clinical stages [33].